Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
SN BioScience
SN BioScience
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)